Immuno-Biological Laboratories Co., Ltd.
Immuno-Biological Laboratories Co., Ltd.
Action · JP3921300004 (XTKS)
Aperçu
Pas de cours
Cours de clôture XTKS 27.10.2025: 478,00 JPY
27.10.2025 05:27
Cours actuels de Immuno-Biological Laboratories Co., Ltd.
BourseTickerDeviseDernier échangeCoursVariation journalière
XTKS: Tokyo
Tokyo
4570.T
JPY
27.10.2025 05:27
478,00 JPY
-4,00 JPY
-0,83 %
Flottant et Liquidité des Actions
Flottant Libre 78,66 %
Actions en Flottant 7,33 M
Actions en Circulation 9,31 M
Profil de l'entreprise pour Immuno-Biological Laboratories Co., Ltd. Action
Immuno-Biological Laboratories Co., Ltd. engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide. The company offers ELILSA, an assay kit to quantitatively measure targeted substances; and support research services on Alzheimer's disease, metabolic syndrome, and cancer, as well as customized services for production of customized antibodies and development of ELISA systems. It also provides LipoSEARCH, a customized services for profiling and analyzing of lipoprotein through gel-filtration high performance liquid chromatography method that can profile various clinical samples, such as tiny plasma or serum samples from both small animals and human beings for broad range of research fields including lipid metabolism, development of drugs for life-style related diseases, development of functional supplemental foods, and clinical studies. In addition, the company offers LipoTEST, a support tool for diagnostic and health checks at animal clinics; and customized biomarker testing services for Life-style related diseases. Further, it operates protein production business using transgenic silkworms for manufacturing of antibodies for research reagents and diagnostic products; human collagen for cosmetic materials; development of proteins for use in drugs; and other proteins production. The company was incorporated in 1982 and is headquartered in Fujioka, Japan.
Obtenez des informations actualisées de finAgent sur Immuno-Biological Laboratories Co., Ltd.

Données de l'entreprise

Nom Immuno-Biological Laboratories Co., Ltd.
Société Immuno-Biological Laboratories Co., Ltd.
Site web https://www.ibl-japan.co.jp
Marché d'origine XTKS Tokyo
ISIN JP3921300004
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Tsutomu Seito
Capitalisation boursière 5 Mrd.
Pays Japon
Devise JPY
Employés 0,1 T
Adresse Fujioka Laboratory, 375-0005 Fujioka
Date d'introduction en bourse 2007-08-15

Symboles boursiers

Nom Symbole
Tokyo 4570.T
Autres actions
Les investisseurs qui détiennent Immuno-Biological Laboratories Co., Ltd. ont également les actions suivantes dans leur portefeuille :
CRED.AGR.ASS 20/30
CRED.AGR.ASS 20/30 Obligation
SELECTA GRP 20/26 REGS
SELECTA GRP 20/26 REGS Obligation
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025